Risk-based mammography screening

Risk-based mammography screening has been studied in 1 paper since 2026: none in people yet; 1 in the past year. No study of it in people or animals has been published yet. The newest paper, Jan 2, 2026: “Five-Year Absolute Risk-Based and Age-Based Breast Cancer Screening in the US”.

Intervention

1 paper studies it2 findingsUpdated

See all 1 papers on risk-based mammography screening

  • In silico1

What did studies of risk-based mammography screening find?

2

Studies of risk-based mammography screening measured 2 outcomes: false-positive recalls and breast cancer mortality.

False-positive recalls

downin silico1

1 study
  1. Risk-based mammography screening decreases false-positive recalls in silico (simulated US women born in 1980) (8% to 23% reduction).

    “as well as reduced false-positive recalls by 8% to 23% (1050-1257 per 1000 women for risk-based screening strategies vs 1365 per 1000 women for B40-74)”

    In silicosimulated US women born in 1980females

    Five-Year Absolute Risk-Based and Age-Based Breast Cancer Screening in the US

    JAMA network open

Breast cancer mortality

downin silico1

1 study
  1. Risk-based mammography screening decreases breast cancer mortality in silico (simulated US women born in 1980) (6.8-7.5 per 1000 women vs 6.8 per 1000 women).

    “Nine risk-based screening strategies were associated with a comparable or greater number of deaths averted than biennial age-based screening from ages 40 to 74 years”

    In silicosimulated US women born in 1980females

    Five-Year Absolute Risk-Based and Age-Based Breast Cancer Screening in the US

    JAMA network open

Latest

Dec 2025: 0Jan 2026: 1Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months